Evidence-Based Medicine

Diabetic Ketoacidosis (DKA) in Children and Adolescents

Diabetic Ketoacidosis (DKA) in Children and Adolescents

Background

  • Diabetic ketoacidosis (DKA) is a common metabolic emergency occurring in patients with diabetes.
    • It is characterized by hyperglycemia and acidosis.
    • It is caused by insulin deficiency, generally due to:
      • insulin noncompliance or mismanagement in patients with known diabetes
      • delayed diagnosis of new-onset diabetes
  • The goal of prompt recognition and treatment is to prevent complications, especially cerebral edema, which is associated with 20%-25% mortality.

Evaluation

  • Common findings at presentation:
    • polydipsia, polyuria, nausea, vomiting, weakness, and lethargy developing over about 24 hours
    • dehydration, Kussmaul respirations (deep respirations), fruity odor on breath, and mental status changes
  • Initial testing should include:
    • serum glucose, electrolytes, ketones, and blood gas
    • urine dipstick and urinalysis
    • electrocardiogram
    • complete blood count with differential
    • renal and liver function tests
  • Diagnostic findings for diabetic ketoacidosis (DKA) are:
    • serum glucose > 200 mg/dL (11 mmol/L)
    • blood pH level < 7.3 or serum bicarbonate level < 18 mEq/L (18 mmol/L)
    • presence of serum or urine ketones

Relevant Calculators

  • Anion Gap Calculator
  • Osmolar Gap Calculator
  • Osmolality Estimator (serum)
  • Sodium Correction in Hyperglycemia

Management

  • Fluids and electrolytes
    • Begin fluid resuscitation with 0.9% saline or Ringer lactate 10-20 mL/kg IV over 20-30 minutes (repeat bolus as needed for shock).
    • After the initial bolus, estimate the degree of dehydration and aim to replace the fluid deficit over 24-48 hours.
      • Avoid infusion rates > 1.5-2 times the maintenance requirement because excessive fluid may increase the risk of cerebral edema.
      • Use 0.45%-0.9% saline or Ringer lactate IV for the first 4-6 hours, then use ≥ 0.45% saline.
    • Add potassium to the IV fluid (if hyperkalemic, defer until urine output established).
    • Consider magnesium supplementation if magnesium < 1.2 mg/dL (0.5 mmol/L, 1 mEq/L).
    • Consider potassium repletion in the form of potassium phosphate if phosphorus < 1 mg/dL (0.32 mmol/L).
  • Insulin and Dextrose
    • Begin insulin therapy after 1 hour of fluid bolus.
      • Administer 0.1 units/kg/hour IV as continuous infusion until diabetic ketoacidosis (DKA) resolves: pH > 7.3, bicarbonate > 18 mEq/L (18 mmol/L), or anion gap < 12 mEq/L (12 mmol/L).
      • Alternatively, 0.05 units/kg/hour dose may be used in milder cases, and in young children with significant sensitivity to insulin as long as metabolic acidosis is resolving.
    • Add 5%-12.5% glucose to the IV fluid when plasma glucose decreases to 250-300 mg/dL (14-17 mmol/L).
    • Consider adding 2.5% or 5% glucose to the rehydration fluid if plasma glucose is decreasing > 100 mg/dL/hour (5.5 mmol/L/hour).
    • Transition to subcutaneous insulin when acidosis has resolved, blood glucose is < 200 mg/dL (11.1 mmol/L), and patient is tolerating oral fluids.

Published: 13-07-2023 Updeted: 13-07-2023

References

  1. Westerberg DP. Diabetic ketoacidosis: evaluation and treatment. Am Fam Physician. 2013 Mar 1;87(5):337-46
  2. Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care. 2006 May;29(5):1150-9
  3. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-856

Related Topics